NewAmsterdam Pharma Wins EU Approval for Ubeslo and Evlarco
Naarden, Netherlands; Florence, Italy; and Miami, U.S., September 21, 2026 NewAmsterdam Pharma and Menarini Group have reached a major...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Naarden, Netherlands; Florence, Italy; and Miami, U.S., September 21, 2026 NewAmsterdam Pharma and Menarini Group have reached a major...
Waltham, Massachusetts, U.S., September 21, 2026 Q32 Bio Inc., a clinical-stage biotechnology company developing therapies for autoimmune and inflammatory...
Salt Lake City, Utah, U.S., September 21, 2026 Co-Diagnostics, Inc. is strengthening its role in global infectious-disease diagnostics and...
